145 related articles for article (PubMed ID: 35351548)
1. Tumor-targeted hyaluronic acid-based oxidative stress nanoamplifier with ROS generation and GSH depletion for antitumor therapy.
Liu Q; Ding X; Xu X; Lai H; Zeng Z; Shan T; Zhang T; Chen M; Huang Y; Huang Z; Dai X; Xia M; Cui S
Int J Biol Macromol; 2022 May; 207():771-783. PubMed ID: 35351548
[TBL] [Abstract][Full Text] [Related]
2. Broaden sources and reduce expenditure: Tumor-specific transformable oxidative stress nanoamplifier enabling economized photodynamic therapy for reinforced oxidation therapy.
Xu X; Huang B; Zeng Z; Chen J; Huang Z; Guan Z; Chen M; Huang Y; Zhao C
Theranostics; 2020; 10(23):10513-10530. PubMed ID: 32929363
[TBL] [Abstract][Full Text] [Related]
3. Tumor microenvironment-responsive nanozymes achieve photothermal-enhanced multiple catalysis against tumor hypoxia.
Lv W; Cao M; Liu J; Hei Y; Bai J
Acta Biomater; 2021 Nov; 135():617-627. PubMed ID: 34407474
[TBL] [Abstract][Full Text] [Related]
4. CD44-specific nanoparticles for redox-triggered reactive oxygen species production and doxorubicin release.
Lin CW; Lu KY; Wang SY; Sung HW; Mi FL
Acta Biomater; 2016 Apr; 35():280-92. PubMed ID: 26853764
[TBL] [Abstract][Full Text] [Related]
5. Glutathione-sensitive mesoporous nanoparticles loaded with cinnamaldehyde for chemodynamic and immunological therapy of cancer.
Zhu L; Li W; Liu C; Yue S; Qiao Y; Cui Y; Cheng J; Zhang M; Zhang P; Zhang B; Hou Y
J Mater Chem B; 2023 Sep; 11(36):8717-8731. PubMed ID: 37646819
[TBL] [Abstract][Full Text] [Related]
6. A multifunctional oxidative stress nanoamplifier with ROS amplification and GSH exhaustion for enhanced chemodynamic therapy.
Zhong W; Guo F; Chen F; Law MK; Lu J; Shao D; Yu H; Chan G; Chen M
Front Pharmacol; 2022; 13():1044083. PubMed ID: 36438812
[TBL] [Abstract][Full Text] [Related]
7. Tumor cell-activated "Sustainable ROS Generator" with homogeneous intratumoral distribution property for improved anti-tumor therapy.
Liu J; Zhao X; Nie W; Yang Y; Wu C; Liu W; Zhang K; Zhang Z; Shi J
Theranostics; 2021; 11(1):379-396. PubMed ID: 33391481
[TBL] [Abstract][Full Text] [Related]
8. CD44 Receptor-Mediated/Reactive Oxygen Species-Sensitive Delivery of Nanophotosensitizers against Cervical Cancer Cells.
Yoon J; Kim H; Jeong YI; Yang HS
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408970
[TBL] [Abstract][Full Text] [Related]
9. pH-responsive hyaluronic acid-based nanoparticles for targeted curcumin delivery and enhanced cancer therapy.
Lai H; Ding X; Ye J; Deng J; Cui S
Colloids Surf B Biointerfaces; 2021 Feb; 198():111455. PubMed ID: 33243547
[TBL] [Abstract][Full Text] [Related]
10. H
Liu Y; Zhou Z; Liu Y; Li Y; Huang X; Qian C; Sun M
Biomater Sci; 2019 Dec; 7(12):5359-5368. PubMed ID: 31621699
[TBL] [Abstract][Full Text] [Related]
11. ROS-responsive fluorinated polyethyleneimine vector to co-deliver shMTHFD2 and shGPX4 plasmids induces ferroptosis and apoptosis for cancer therapy.
Yang S; Wong KH; Hua P; He C; Yu H; Shao D; Shi Z; Chen M
Acta Biomater; 2022 Mar; 140():492-505. PubMed ID: 34879292
[TBL] [Abstract][Full Text] [Related]
12. Reactive oxygen species-activatable self-amplifying Watson-Crick base pairing-inspired supramolecular nanoprodrug for tumor-specific therapy.
Xu X; Zeng Z; Ding X; Shan T; Liu Q; Chen M; Chen J; Xia M; He Y; Huang Z; Huang Y; Zhao C
Biomaterials; 2021 Oct; 277():121128. PubMed ID: 34537502
[TBL] [Abstract][Full Text] [Related]
13. Tumor-specific activated photodynamic therapy with an oxidation-regulated strategy for enhancing anti-tumor efficacy.
Liang H; Zhou Z; Luo R; Sang M; Liu B; Sun M; Qu W; Feng F; Liu W
Theranostics; 2018; 8(18):5059-5071. PubMed ID: 30429886
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronic acid-coated chitosan nanoparticles induce ROS-mediated tumor cell apoptosis and enhance antitumor efficiency by targeted drug delivery via CD44.
Wang T; Hou J; Su C; Zhao L; Shi Y
J Nanobiotechnology; 2017 Jan; 15(1):7. PubMed ID: 28068992
[TBL] [Abstract][Full Text] [Related]
15. Intracellular delivery and antitumor effects of a redox-responsive polymeric paclitaxel conjugate based on hyaluronic acid.
Yin S; Huai J; Chen X; Yang Y; Zhang X; Gan Y; Wang G; Gu X; Li J
Acta Biomater; 2015 Oct; 26():274-85. PubMed ID: 26300335
[TBL] [Abstract][Full Text] [Related]
16. A Novel Polyamino Acid Sulfur Dioxide Prodrug Synergistically Elevates ROS with β-Lapachone in Cancer Treatment.
Tang B; Zhang Y; Liu X; Wang Y; He P
J Pharm Sci; 2024 May; 113(5):1239-1247. PubMed ID: 38042342
[TBL] [Abstract][Full Text] [Related]
17. Phenethyl isothiocyanate induces DNA damage-associated G2/M arrest and subsequent apoptosis in oral cancer cells with varying p53 mutations.
Yeh YT; Yeh H; Su SH; Lin JS; Lee KJ; Shyu HW; Chen ZF; Huang SY; Su SJ
Free Radic Biol Med; 2014 Sep; 74():1-13. PubMed ID: 24952138
[TBL] [Abstract][Full Text] [Related]
18. A mitochondria-targeting ROS-activated nanoprodrug for self-augmented antitumor oxidation therapy.
Zeng Z; Luo Y; Xu X; Shan T; Chen M; Huang Z; Huang Y; Zhao C
J Control Release; 2023 Jul; 359():415-427. PubMed ID: 37290720
[TBL] [Abstract][Full Text] [Related]
19. Photo-induced specific intracellular release EGFR inhibitor from enzyme/ROS-dual sensitive nano-platforms for molecular targeted-photodynamic combinational therapy of non-small cell lung cancer.
Zhang M; Zhang X; Cai S; Mei H; He Y; Huang D; Shi W; Li S; Cao J; He B
J Mater Chem B; 2020 Sep; 8(35):7931-7940. PubMed ID: 32779670
[TBL] [Abstract][Full Text] [Related]
20. Redox-Responsive and Dual-Targeting Hyaluronic Acid-Methotrexate Prodrug Self-Assembling Nanoparticles for Enhancing Intracellular Drug Self-Delivery.
Zhang Y; Li Y; Tian H; Zhu Q; Wang F; Fan Z; Zhou S; Wang X; Xie L; Hou Z
Mol Pharm; 2019 Jul; 16(7):3133-3144. PubMed ID: 31198046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
